Webinar: Draft Guidances on Transition Plans for COVID-19 Related Medical Devices

Join us on February 22 to ask your questions about the draft guidances on transition plans for COVID-19 related medical devices.

If your email program has trouble displaying this email, view as a webpage. Reminder: Join Us for a Webinar - Draft Guidances on Transition Plans for COVID-19 Related Medical Devices The U.S. Food and Drug Administration (FDA) will host a webinar to share information and answer questions about the draft guidances on transition plans for COVID-19 related medical devices. Date: Tuesday, February 22, 2022 Time: 1:00 PM - 2:30 PM ET Registration: No registration required. View webinar details for call-in information. To ensure you are connected, please join 15 minutes prior to the start of webinar. View Details During this webinar, the FDA will: Help prepare manufacturers and other stakeholders for the orderly and transparent transition to normal operations Describe recommendations regarding submitting a marketing submission and the timeline for doing so Provide examples to illustrate the transition policies and exemplify the 180-day transition period timeline Answer your questions about the draft guidances on COVID-19 transition plans Questions? If you have questions, contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA